Press Releases

In This Section

Breadcrumb

Home // Investors // Press Releases //

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Aegerion Pharmaceuticals Appoints Marc Beer as CEO
Aegerion Pharmaceuticals Appoints Marc Beer as CEO BRIDGEWATER, NJ– September 13, 2010 – Aegerion Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, today announced that Marc Beer has joined the
View HTML
Toggle Summary Aegerion Pharmaceuticals Announces Additional Lomitapide (AEGR-733) Phase III Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Safety Profile
Results Will Be Presented Today At AHA Conference in Orlando, Florida
View HTML
Toggle Summary Aegerion Pharmaceuticals Announces Final Lomitapide (AEGR-733) Phase II Data
Results Confirm Preliminary Data and Demonstrate Strong Efficacy, Safety and Tolerability Profile of Lomitapide
View HTML
Toggle Summary Aegerion Pharmaceuticals Announces Interim Lomitapide (AEGR-733) Phase III Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Hepatic Safety Profile
Webcast of Company-Sponsored Symposium to Review Clinical Data Scheduled for June 16th 2009, 12:30-2:00 pm ET at the ISA (International Symposium on Atherosclerosis) in Boston, MA
View HTML